#lungcancer #lungcancerawareness #lungcancerawarenessmonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #SCLC #NSCLC #thoracictumors #thoraciconcology #precisiononcology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #cancersurvivorship #breastcancer #oncology
#lungcancer #lungcancerawareness #LungCancerAwarenessMonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #sclc #NSCLC #thoracictumors #thoraciconcology #PrecisionOncology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #CancerSurvivorship #breastcancer
#lungcancer #lungcancerawareness #lungcancerawarenessmonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #SCLC #NSCLC #thoracictumors #thoraciconcology #precisiononcology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #cancersurvivorship #breastcancer #oncology #immunology #immunotherapy #genetherapy #cancer #cancerawareness
#lungcancer #lungcancerawareness #LungCancerAwarenessMonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #sclc #NSCLC #thoracictumors #thoraciconcology #PrecisionOncology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #CancerSurvivorship #breastcancer #immunology #Immunotherapy #genetherapy #cancerawareness
A huge thank you to @PTarantinoMD & @drsarahsam for presenting a whirlwind #TumorBoardTuesday. Amazing to see how we're learning to better use CDK4/6i in #mBC, and how #precisiononcology provides new options in the 2L setting. Check out the summary below. Happy weekend!
---
RT @JohnEbbenMDPhD
@TumorBoardTues @drsarahsam @PTarantinoMD @stolaney1 @MPishvaian @BreastCaupdates @BCRFcure @BCAction @LivingBeyondBC @RenoHemonc 3/5 #TumorBo…
https://twitter.com/JohnEbbenMDPhD/status/1631674649305030656
#TumorBoardTuesday #MBC #PrecisionOncology #tumorbo
RT @CGIclinics: Join us in person or online for this one hour event at the EU Parliament in Brussels, Belgium to discuss the aims of CGI-Clinics & its relevance in policy-making. All are welcome!
👉 Register by 15 March: https://docs.google.com/forms/d/e/1FAIpQLSdtUtnbDsFEKBRcrQe8xsri_ymIwMPv635tajiNKPXzOOj25g/viewform?usp=send_form
#CancerResearch #PrecisionOncology
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1628740831032082432
#cancerresearch #PrecisionOncology
This is probably THE largest KRAS focused mutational database across human cancers I have seen, courtesy of @FoundationATCG & linked to outcomes.
23% of >426,000 adult cancers carry KRAS mutations.
#OpenAccess in @Nature_NPJ #PrecisionOncology
Details 👉🏽
https://www.nature.com/articles/s41698-022-00334-z
#PancreaticCancer is the biggest enchilada when it comes to somatic KRAS alterations. The data also contains information on significant co-occurring & mutually exclusive mutations.
#openaccess #PrecisionOncology #pancreaticcancer
#medicine #meded #precisionmedicine #precisiononcology #precisionhealth #oncology #genetherapy #diagnostics #leader #womeninscience #womeninmedicine #womeninstem #globalleader #globalleadership #globalleaders #personalizedmedicine #rarediseaseday #rarediseases #raredisease #rarediseaseawareness #rarediseaseday2022 #rarediseaseresearch #rarediseasemonth #precisionvoice #precisionleader #womeninscience #sarcoma #immunology #immunotherapy #immunediagnostics #diagnostics #personalizedmedicine
#medicine #MedEd #precisionmedicine #PrecisionOncology #precisionhealth #oncology #genetherapy #diagnostics #leader #WomenInScience #WomenInMedicine #womeninstem #globalleader #globalleadership #globalleaders #PersonalizedMedicine #rarediseaseday #rarediseases #RareDisease #rarediseaseawareness #rarediseaseday2022 #rarediseaseresearch #rarediseasemonth #precisionvoice #precisionleader #sarcoma #immunology #Immunotherapy #immunediagnostics
RT @ScienceVancity
.@BCCancer scientists want to help decision-makers better understand which cancer treatments should be offered to patients.
"Our goal is to achieve timely patient access to #PrecisionOncology that improves population health,” says Dr. @DeanRegier.
Lobular #BreastCancer is molecularly different from IDC. #ctDNA mutations in CDH1, ERBB2, PTEN were associated with ILC. Similarly, CDH1 was co-mutated with PIK3CA, ERBB2 and ET resistance alterations in a cohort of ~7000 #MBC patients #bcsm #LiquidBiopsy #PrecisionOncology #precisionmedicine
https://www.sciencedirect.com/science/article/pii/S2352396422004984
#breastcancer #ctDNA #MBC #bcsm #LiquidBiopsy #PrecisionOncology #precisionmedicine